Yukie Takimoto

999 total citations
29 papers, 785 citations indexed

About

Yukie Takimoto is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Yukie Takimoto has authored 29 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Yukie Takimoto's work include Renal cell carcinoma treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Yukie Takimoto is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Yukie Takimoto collaborates with scholars based in Japan, United States and Germany. Yukie Takimoto's co-authors include Sadatsugu Minei, Norimichi Nemoto, Daisaku Hirano, Yasuhiro Okada, Yoshio Aso, Hitoshi Kato, Kazuki Kawabe, Akira Ueno, Nozomu Kawata and Takahiko Hachiya and has published in prestigious journals such as Cancer, The Journal of Urology and European Urology.

In The Last Decade

Yukie Takimoto

29 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukie Takimoto Japan 12 465 235 172 143 131 29 785
S. Ozono Japan 15 312 0.7× 294 1.3× 79 0.5× 106 0.7× 95 0.7× 74 698
David Grignon United States 12 669 1.4× 156 0.7× 97 0.6× 95 0.7× 101 0.8× 26 965
Masahiro Yashi Japan 14 244 0.5× 132 0.6× 84 0.5× 148 1.0× 64 0.5× 50 544
A. Eisenhardt Germany 16 97 0.2× 257 1.1× 119 0.7× 139 1.0× 103 0.8× 48 729
Yasuyoshi Fujiuchi Japan 14 150 0.3× 118 0.5× 57 0.3× 115 0.8× 82 0.6× 45 512
Ryuta Tanimoto Japan 20 238 0.5× 391 1.7× 74 0.4× 127 0.9× 66 0.5× 46 850
Shimiao Zhu China 19 388 0.8× 525 2.2× 32 0.2× 192 1.3× 327 2.5× 38 1.0k
Piero De Carli Italy 15 209 0.4× 221 0.9× 174 1.0× 135 0.9× 102 0.8× 34 821
Teruaki Kumazawa Japan 16 243 0.5× 264 1.1× 34 0.2× 124 0.9× 139 1.1× 43 649
Pam Unger United States 11 451 1.0× 123 0.5× 48 0.3× 65 0.5× 60 0.5× 17 682

Countries citing papers authored by Yukie Takimoto

Since Specialization
Citations

This map shows the geographic impact of Yukie Takimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukie Takimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukie Takimoto more than expected).

Fields of papers citing papers by Yukie Takimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukie Takimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukie Takimoto. The network helps show where Yukie Takimoto may publish in the future.

Co-authorship network of co-authors of Yukie Takimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yukie Takimoto. A scholar is included among the top collaborators of Yukie Takimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukie Takimoto. Yukie Takimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirano, Daisaku, Yukie Takimoto, Katsuhiko Satoh, et al.. (2006). Effects of Chinese Herbal Medicine (Hochuekitoh) for Patients with Electile Dysfunction : Kinetics of Serum Testosterone levels. 21(3). 249–254. 1 indexed citations
2.
Sato, Hirotaka, Sadatsugu Minei, Takahiko Hachiya, Toshio Yoshida, & Yukie Takimoto. (2006). Fluorescence in situ hybridization analysis of c‐myc amplification in stage T3N0M0 prostate cancer in Japanese patients. International Journal of Urology. 13(6). 761–766. 33 indexed citations
3.
Kawata, Nozomu, et al.. (2006). Strong significant correlation between MMP-9 and systemic symptoms in patients with localized renal cell carcinoma. Urology. 68(3). 523–527. 20 indexed citations
4.
Kawata, Nozomu, et al.. (2006). Usefulness of contrast‐enhanced ultrasound for the diagnosis of recurrent renal cell carcinoma in contralateral kidney. International Journal of Urology. 13(3). 325–328. 5 indexed citations
5.
Hirano, Daisaku, Yasuhiro Okada, Sadatsugu Minei, et al.. (2005). Immunohistochemical and Ultrastructural Features of Neuroendocrine Differentiated Carcinomas of the Prostate: An Immunoelectron Microscopic Study. Ultrastructural Pathology. 29(5). 367–375. 12 indexed citations
6.
Kawata, Nozomu, et al.. (2005). Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma. Urology. 66(4). 736–740. 4 indexed citations
7.
Hirano, Daisaku, Sadatsugu Minei, Kenya Yamaguchi, et al.. (2005). Prospective Study of Estramustine Phosphate for Hormone Refractory Prostate Cancer Patients following Androgen Deprivation Therapy. Urologia Internationalis. 75(1). 43–49. 17 indexed citations
8.
Hachiya, Takahiko, Yasuhiro Okada, Nozomu Kawata, et al.. (2004). Long‐term survival following radical prostatectomy in Japanese men with clinically localized prostate cancer: A single institutional study. International Journal of Urology. 11(10). 862–869. 3 indexed citations
9.
Sato, Hirotaka, et al.. (2004). Multicentric liposarcoma. International Journal of Urology. 11(12). 1133–1135. 12 indexed citations
10.
Hirano, Daisaku, Yasuhiro Okada, Sadatsugu Minei, Yukie Takimoto, & Norimichi Nemoto. (2004). Neuroendocrine Differentiation in Hormone Refractory Prostate Cancer Following Androgen Deprivation Therapy. European Urology. 45(5). 586–592. 238 indexed citations
11.
Kawata, Nozomu, et al.. (2003). Histopathological analysis of angiogenic factors in renal cell carcinoma. International Journal of Urology. 10(4). 220–227. 52 indexed citations
12.
Maass, Nicolaì, Yukie Takimoto, Katsuhiko Sato, et al.. (2003). Expression and regulation of tumor suppressor gene maspin in human bladder cancer. Cancer Letters. 203(2). 209–215. 38 indexed citations
13.
Hachiya, Takahiko, Sadatsugu Minei, Daisaku Hirano, et al.. (2002). ADJUVANT HORMONE THERAPY IN PATIENTS WITH POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY. The Japanese Journal of Urology. 93(3). 469–475. 3 indexed citations
14.
Kawata, Nozomu, et al.. (2001). Histopathologic analysis of angiogenic factors in localized renal cell carcinoma: The influence of neoadjuvant treatment. International Journal of Urology. 8(6). 275–281. 10 indexed citations
15.
Kawata, Nozomu, et al.. (2000). Cytoreductive surgery with liver‐involved renal cell carcinoma. International Journal of Urology. 7(10). 382–385. 11 indexed citations
16.
17.
Takimoto, Yukie, et al.. (1999). THE EFFECT OF 5-HT 2 ANTAGONIST FOR URINARY FREQUENCY SYMPTOM ON DIABETES MELLITUS PATIENTS. The Japanese Journal of Urology. 90(8). 731–740. 8 indexed citations
18.
Kawata, Naoko, et al.. (1999). Multivariate analysis of clinicopathologic factors and the efficacy of postoperative IFN-γ adjuvant therapy in 115 patients with renal cell carcinoma. International Journal of Clinical Oncology. 4(3). 164–169. 3 indexed citations
19.
Hirano, Daisaku, et al.. (1997). Electron Microscopic Study of the Penile Plaques and Adjacent Corpora Cavernosa in Peyronie's Disease. International Journal of Urology. 4(3). 274–278. 10 indexed citations
20.
Kawabe, Kazuki, Akira Ueno, Yukie Takimoto, Yoshio Aso, & Hitoshi Kato. (1990). Use of an α1-Blocker, YM617, in the Treatment of Benign Prostatic Hypertrophy. The Journal of Urology. 144(4). 908–911. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Ozono Breakdown of academic impact, for papers by David Grignon Breakdown of academic impact, for papers by Masahiro Yashi Breakdown of academic impact, for papers by A. Eisenhardt Breakdown of academic impact, for papers by Yasuyoshi Fujiuchi Breakdown of academic impact, for papers by Ryuta Tanimoto Breakdown of academic impact, for papers by Shimiao Zhu Breakdown of academic impact, for papers by Piero De Carli Breakdown of academic impact, for papers by Teruaki Kumazawa Breakdown of academic impact, for papers by Pam Unger
Rankless by CCL
2026